Update on genetic and molecular markers associated with myelodysplastic syndromes. (Q37407161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

review article

1 reference

title

Update on genetic and molecular markers associated with myelodysplastic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

Rotraud Wieser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Peter Valent

series ordinal

1

1 reference

20 August 2017

Rotraud Wieser

series ordinal

2

1 reference

20 August 2017

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

341-348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

Proposals for the classification of the myelodysplastic syndromes

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Chromosome and molecular abnormalities in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Myelodysplastic syndrome: review of the cytogenetic and molecular data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Molecular mechanisms of leukemogenesis by AML1/EVI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

EVI1 induces myelodysplastic syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Biology and clinical features of myeloid neoplasms with inv(3)(q21q26) or t(3;3)(q21q26).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Cytogenetic features in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Mutations of the Kirsten-ras proto-oncogene in human preleukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Myelodysplastic syndromes: molecular pathogenesis and genomic changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

AML1 mutations induced MDS and MDS/AML in a mouse BMT model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Diagnosis and treatment of systemic mastocytosis: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Mastocytosis: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Acquired somatic ATRX mutations in myelodysplastic syndrome associated with α thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Familial myelodysplasia and acute myeloid leukaemia--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Myelodysplastic syndromes: iron overload consequences and current chelating therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Iron overload in myelodysplastic syndromes (MDS) - diagnosis, management, and response criteria: a proposal of the Austrian MDS platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Gene expression profiling in the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

High-resolution whole genome tiling path array CGH analysis of CD34 cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/10428190902756107

10.1080/10428190902756107

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19263296 AND SRC:MED&resulttype=core&format=json

22 January 2020

1 reference